Randomised controlled trial comparing two treatment methods for symptomatic haemorrhoidal disease

Not Applicable

Completed

• Conditions: Circumferential grade II symptomatic haemorrhoids; Circulatory System; Haemorrhoids

• Registration Number: ISRCTN23585705
• Lead Sponsor: niversity of Aberdeen Medicines Assessment Research Unit (MARU)

Brief Summary

2010 results in http://www.ncbi.nlm.nih.gov/pubmed/19508532

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-04-02
• Study Start: 2008-06-23
• Last Update Posted: 21 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Circumferential grade II symptomatic haemorrhoids irrespective of age and gender.

Exclusion Criteria

1. Associated anaorctal sepsis
2. Associated colonic malignancy or inflammatory bowel disease
3. Associated anal sphincter pathology

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease recurrence at six weeks and one year.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Symptom score (validated and published already)<br> 2. Cleveland continence score<br> 3. Quality of life score (36-item Short Form health survey [SF-36], EuroQoL instrument [EQ-5D] and Hospital Anxiety and Depression Scale [HAD] scores)<br> 4. Cost effectiveness<br> 5. Sphincter damage<br><br> All secondary outcomes were assessed at 6 weeks, 26 weeks and one year.<br>